Investing Profile

Stacey Seltzer

VC

Photo of Stacey Seltzer, Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Aisling Capital Partner
2
$280M
CompanyStageDateRound SizeTotal Raised
Aimmune Therapeutics
Series BMar 2015$80M
$80M
Co-investors: Jim Tananbaum (Foresite Capital)
Agile Therapeutics
Post-IPO EquityFeb 2015$20M
$60M
Co-investors: Andrew Schiff (Aisling Capital)